microRNA-564 Inhibits the Aggressive Phenotypes of Papillary Thyroid Cancer by Directly Targeting Astrocyte-Elevated Gene-1 [Retraction]
Song Z, Yang H, Wu X, Kong C, Xu C. Onco Targets Ther. 2019;12:4869–4881. The Editor and Publisher of OncoTargets and Therapy wish to retract the published article. Concerns were raised over alleged image duplication in Figures 2C and 8A with similar images from unrelated articles, specifi...
Main Authors: | Song Z, Yang H, Wu X, Kong C, Xu C |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2021-09-01
|
Series: | OncoTargets and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/retraction-microrna-564-inhibits-the-aggressive-phenotypes-of-papillar-peer-reviewed-fulltext-article-OTT |
Similar Items
-
microRNA-564 inhibits the aggressive phenotypes of papillary thyroid cancer by directly targeting astrocyte-elevated gene-1
by: Song Z, et al.
Published: (2019-06-01) -
The age threshold of the 8th edition AJCC classification is useful for indicating patients with aggressive papillary thyroid cancer in clinical practice
by: Krzysztof Kaliszewski, et al.
Published: (2020-11-01) -
PREDICTORS OF AGGRESSIVE DIFFERENTIATED THYROID CANCER. A REPORT OF A CASE OF PAPILLARY THYROID CANCER
by: R. A. Murashko, et al.
Published: (2017-11-01) -
Which papillary thyroid microcarcinoma should be treated as “true cancer” and which as “precancer”?
by: Krzysztof Kaliszewski, et al.
Published: (2019-05-01) -
BRAF V600E expression found in aggressive papillary thyroid carcinoma (PTC), lymph node metastasis, and extra-thyroid extension
by: Made Priska Rusmana, et al.
Published: (2018-10-01)